tiprankstipranks
Trending News
More News >
Bio-Rad Laboratories (BIO)
NYSE:BIO
US Market

Bio-Rad Laboratories (BIO) Income Statement

Compare
918 Followers

Bio-Rad Laboratories Income Statement

Last quarter (Q3 2025), Bio-Rad Laboratories's total revenue was $653.00M, an increase of 0.50% from the same quarter last year. In Q3, Bio-Rad Laboratories's net income was $-341.90M. See Bio-Rad Laboratories’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.57B$ 2.67B$ 2.80B$ 2.92B$ 2.55B
Gross Profit
$ 1.38B$ 1.43B$ 1.57B$ 1.64B$ 1.44B
Operating Expenses
$ 1.11B$ 1.09B$ 1.08B$ 1.14B$ 1.02B
Depreciation and Amortization
$ 151.60M$ 145.90M$ 177.20M$ 137.60M$ 138.60M
EBITDA
$ -2.14B$ -654.80M$ -4.49B$ 5.59B$ 5.08B
Operating Income
$ 269.00M$ 337.80M$ 482.62M$ 500.34M$ 421.33M
Other Income/Expenses
$ -2.61B$ -1.19B$ -5.19B$ 4.95B$ 4.50B
Pretax Income
$ -2.34B$ -850.10M$ -4.70B$ 5.45B$ 4.92B
Net Income
$ -1.84B$ -637.32M$ -3.63B$ 4.25B$ 3.81B
Per Share Metrics
Basic EPS
$ -65.36$ -21.82$ -121.79$ 142.61$ 127.86
Diluted EPS
$ -65.36$ -21.82$ -121.79$ 140.83$ 126.20
Weighted Average Shares Outstanding
28.21M 29.21M 29.79M 29.83M 29.77M
Weighted Average Shares Outstanding (Diluted)
28.21M 29.21M 29.79M 30.21M 30.16M
Currency in USD

Bio-Rad Laboratories Earnings and Revenue History